• Jump to content
  • Jump to navigation
  • Jump to search
Bionor Pharma 2012
Search
  • Home
  • Vaccines & technology
  • News
  • Investors
  • About Bionor Pharma
  • Contact us
  • Sitemap
  • You are here:
    1. Frontpage
    2. Sitemap

Sitemap

  • Home
  • Vaccines & technology
    • Platform technology
      • legacy files
    • HIV vaccine Vacc-4x
    • HIV vaccine Vacc-C5
    • Pipeline
    • Hepatitis C (HCV)
    • Influenza
    • Other Indications
    • History
    • Publications
    • Clinical Advisory Board
    • Scientific Advisory Board
    • Brochure
  • News
    • 2013
      • All
      • Scientific
      • Financial
      • Media Coverage
    • 2012
      • All
      • Scientific
      • Financial
      • Media Coverage
    • 2011
      • All
      • Scientific
      • Financial
      • Media Coverage
    • 2010
      • All
      • Scientific
      • Nutraceutical
      • Financial
    • 2009
      • All
      • Vaccine
      • Neutraceutical
      • Investor
    • 2008
      • All
      • Vaccine
      • Nutraceutical
      • Investor
    • 2007
      • All
      • Vaccine
      • Nutraceutical
      • Investor
    • 2006
      • All
      • Vaccine
      • Nutriceutical
      • Investor
    • Earlier
      • All
  • Investors
    • Share information
    • Business model
    • Financial reports
    • Governance
    • 20 largest shareholders
    • Downloads
    • Financial calendar
  • About Bionor Pharma
    • Board of Directors
      • Legacy files
    • Management
    • Clinical Advisory Board
    • Scientific Advisory Board
    • Nutraceuticals
    • Contact us
  • Contact us
  • Sitemap

Latest News Full archive ››

  • Annual General Meeting Strengthens the Board of Directors with Financial and Regulatory CompetenciesFinancial 15.05.2013
  • Invitation to Annual General Meeting 15 May 2013Financial 24.04.2013

CalendarFull calendar ››

  • Feb 15Financial calendar 2013 for Bionor Pharma ASA

E-mail alert More info ››

      • Home
      • Vaccines & technology
      • News
      • Investors
      • About Bionor Pharma
      • Contact us
      • Sitemap
    • Bionor Pharma ASA Kronprinsesse Märthas Plass 1 P.O. Box 1477 Vika, NO-0116 Oslo, Norway, Tel.: +47 23 01 09 60, Fax +47 23 01 09 70 

      Site by Pinpoint & Idium